Publication | Closed Access

The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis

InflammationThrombosisVascular DiseaseCardiovascular DiseasePhysiologyPharmacologyVascular BiologyPharmacotherapyPlaque RegressionExperimental AtherosclerosisMedicineAtherosclerosisAdditive EffectDyslipidemiaOxidative Stress